Published in Medical Letter on the CDC and FDA, March 18th, 1996
In response to the resurgence of tuberculosis the U.S. Centers for Disease Control and Prevention (CDC) recommended the use of certain mycobacteriology laboratory methods to improve the accuracy of diagnosis and/or minimize times to complete specimen processing.
In this study researcher Jerome I. Tokars and colleagues examined the extent to which these recommended methods were being used in hospital laboratories (U.S Hospital Mycobacterial Laboratories: Status and Comparison with State Public Health Department...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.